(PRWEB) April 26, 2013
The US Drug Watchdog is receiving daily complaints from victims of severe transvaginal mesh failures regarding the fact the doctor, or surgeon who implanted the device-will not return their phone calls? Supposedly the procedure to install a transvaginal mesh implant was going to be minimally invasive. The US Drug Watchdog says, "The FDA is now saying transvaginal mesh failures are causing complications in patients such as erosion and infection. Women who experience transvaginal mesh failure may need to have numerous corrective surgeries." The US Drug Watchdog is offering to help all US women, who are now victims of a severe transvaginal mesh failure, and they are urging these people to call them for the names of best possible attorneys, and the group is promising the attorneys will all be women, because the damages are so gender specific. For more information victims of a severe transvaginal mesh failure are urged to contact the US Drug Watchdog anytime at 866-714-646.
The US Drug Watchdog is indicating symptoms of a vaginal mesh implant failure may include:
The US Drug Watchdog says, "One of the biggest problems we have with respect to our failed medical device or recalled drug initiative work is the average US consumer never hears about a drug recall or failures involving medical devices like the transvaginal mesh failures. If you have a friend, or loved one who is a recipient of a transvaginal mesh type product that has already failed or is showing symptoms of a failure, please have them call us at 866-714-6466. We need to emphasize we are talking about women in all 50 states including New York, California, Ohio, Florida, Texas, Washington, Nebraska, Maine, etc. We want to make certain transvaginal mesh failure victims get to the best possible attorneys, to ensure they get the best possible compensation for their ordeal, and we will do our absolute best to make certain all of the attorneys are women." http://USDrugWatchdog.Com
U.S. District Court for the Southern District of West Virginia Multidistrict litigation (MDL) consolidates all similar cases into one courtroom and will include the Defendants:
C.R. Bard, Inc., (MDL No. 2187);
American Medical Systems Inc., MDL No. 2325);
Boston Scientific Corp., (MDL No. 2326); and Johnson & Johnson's Ethicon, Inc. (MDL No. 2327)
Read the full story at http://www.prweb.com/releases/2013/4/prweb10650896.htm.
Copyright©2012 Vocus, Inc.
All rights reserved